14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Nov 04, 2016 $18.80 $18.80 $18.80 $18.80 64 513
Nov 03, 2016 $16.88 $16.88 $16.88 $16.88 49 975
Nov 02, 2016 $18.16 $18.16 $18.16 $18.16 60 513
Nov 01, 2016 $18.96 $18.96 $18.96 $18.96 78 513
Oct 31, 2016 $17.60 $17.60 $17.60 $17.60 60 838
Oct 28, 2016 $17.36 $17.36 $17.36 $17.36 73 763
Oct 27, 2016 $18.40 $18.40 $18.40 $18.40 76 913
Oct 26, 2016 $19.52 $19.52 $19.52 $19.52 40 488
Oct 25, 2016 $20.08 $20.08 $20.08 $20.08 35 325
Oct 24, 2016 $21.68 $21.68 $21.68 $21.68 97 238
Oct 21, 2016 $21.68 $21.68 $21.68 $21.68 96 150
Oct 20, 2016 $20.48 $20.48 $20.48 $20.48 171 250
Oct 19, 2016 $20.40 $20.40 $20.40 $20.40 99 113
Oct 18, 2016 $22.08 $22.08 $22.08 $22.08 45 075
Oct 17, 2016 $22.96 $22.96 $22.96 $22.96 65 063
Oct 14, 2016 $23.44 $23.44 $23.44 $23.44 60 488
Oct 13, 2016 $24.08 $24.08 $24.08 $24.08 33 538
Oct 12, 2016 $24.08 $24.08 $24.08 $24.08 60 888
Oct 11, 2016 $25.04 $25.04 $25.04 $25.04 35 025
Oct 10, 2016 $25.68 $25.68 $25.68 $25.68 43 750
Oct 07, 2016 $25.12 $25.12 $25.12 $25.12 39 400
Oct 06, 2016 $25.60 $25.60 $25.60 $25.60 64 113
Oct 05, 2016 $26.56 $26.56 $26.56 $26.56 87 150
Oct 04, 2016 $25.68 $25.68 $25.68 $25.68 60 925
Oct 03, 2016 $25.60 $25.60 $25.60 $25.60 132 588
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT